Congenital disorder of glycosylation (CDG) type Ie.: A new patient

被引:36
作者
García-Silva, MT
Matthijs, G
Schollen, E
Cabrera, JC
Del Pozo, JS
Herreros, MM
Simón, R
Maties, M
Hernández, EM
Hennet, T
Briones, P
机构
[1] Hosp 12 Octubre, Unidad Enfermedades Mitocondriales Enfermedades M, Dept Paediat, E-28041 Madrid, Spain
[2] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium
[3] Hosp Materno Infantil, Dept Paediat, Las Palmas Gran Canaria, Spain
[4] Hosp Ramon y Cajal, Dept Biochem, E-28034 Madrid, Spain
[5] Univ Zurich, Inst Physiol, Zurich, Switzerland
[6] Corp Sanitaria Clin, Inst Bioquim Clin, Barcelona, Spain
[7] CSIC, Barcelona, Spain
关键词
D O I
10.1023/B:BOLI.0000042984.42433.d8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CDG Ie is caused by a deficiency of dolichol-phosphate-mannose synthase 1 (DPM1), an enzyme involved in N-glycan assembly in the endoplasmic reticulum. Three proteins are known to be part of the synthase complex: DPM1, DPM2 and DPM3. Only mutations in DPM1, the catalytic subunit, have been described in three families. One was homozygous for the c274C>G (R92G) mutation in DPM1 and two others were compound heterozygous for R92G and a c628delC deletion or a c331-343del13, respectively. Clinical features were a severe infantile encephalopathy, early intractable seizures, acquired microcephaly, and some dysmorphic features. We report a patient with milder symptoms: microcephaly, dysmorphic features, developmental delay, optic atrophy, and cerebellar dysfunction without cerebellar atrophy. The patient is homozygous for a new mutation in exon 9 of the DPM1 gene (c742T>C (S248P)). Our findings extend the spectrum of CDG Ie.
引用
收藏
页码:591 / 600
页数:10
相关论文
共 8 条
[1]  
Briones P, 2001, Eur J Paediatr Neurol, V5, P127, DOI 10.1053/ejpn.2001.0483
[2]   The dolichol pathway of N-linked glycosylation [J].
Burda, P ;
Aebi, M .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1426 (02) :239-257
[3]   Personal experience with the application of carbohydrate-deficient transferrin (CDT) assays to the detection of congenital disorders of glycosylation [J].
Colomé, C ;
Ferrer, I ;
Artuch, R ;
Vilaseca, MA ;
Pineda, M ;
Briones, P .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (10) :965-969
[4]   Congenital disorders of glycosylation:: A review [J].
Grünewald, S ;
Matthijs, G ;
Jaeken, J .
PEDIATRIC RESEARCH, 2002, 52 (05) :618-624
[5]   Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie [J].
Imbach, T ;
Schenk, B ;
Schollen, E ;
Burda, P ;
Stutz, A ;
Grünewald, S ;
Bailie, NM ;
King, MD ;
Jaeken, J ;
Matthijs, G ;
Berger, EG ;
Aebi, M ;
Hennet, T .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (02) :233-239
[6]  
Kim BI, 2000, MAX PLANCK SERIES, V1, P105
[7]  
Kinoshita T, 1999, GLYCOBIOLOGY, V9, P1104
[8]   DHPLC analysis as a platform for molecular diagnosis of congenital disorders of glycosylation (CDG) [J].
Schollen, E ;
Martens, K ;
Geuzens, E ;
Matthijs, G .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (10) :643-648